When important steps for a reliable Meta-analysis are missing: the bevacizumab versus ranibizumab case

作     者：Valentino Conti Mauro Venegoni Ugo Moretti Corrado Barbui 

作者机构：Regional Pharmacovigilance Centre of Lombardy Regional Pharmacovigilance Centre of Veneto Section of PsychiatryDepartment of Public Health and Community MedicineUniversity of VeronaPoliclinico GB Rossi 

出 版 物：《International Journal of Ophthalmology(English edition)》 (国际眼科杂志（英文版）)

年 卷 期：2015年第8卷第1期

页      面：204-205页

核心收录：

学科分类：1002[医学-临床医学] 100212[医学-眼科学] 10[医学] 

主　　题：the bevacizumab versus ranibizumab case When important steps for a reliable Meta-analysis are missing than 

摘      要：Dear Sir,W e have read with attention and interest the systematic review on the effectiveness and safety of bevacizumab and ranibizumab in the treatment of age-related macular degeneration(AMD)written by Zhang et al[1]and published on number of April 2014 of International Journal of *** authors,who collected data from 4randomized clinical trials(RCTs)and 11 observational